Recruited to lead the commercial team in the development of the worldwide launch strategy for NEVOTM, a billion dollar opportunity in the cardiovascular stent market. Responsible for leading a worldwide cross functional team in the creation of foundational marketing elements and life cycle plan. Assumed leadership role on team responsible for establishing new Cordis Global Portfolio Strategy and Positioning. Global roll out of market development strategy in advance of NEVO launch Obtained Management Board endorsement of pricing and reimbursement strategy Instituted commercial processes that have been adopted as S.O.P across the global organization

Led team of 11 experienced marketers across three hospital anti-infectives with annual sales of $420MM and $45MM marketing investments. Collaborated with Medical Affairs, Regulatory and Analytics in identifying and quantifying potential opportunities for product lifecycle development. Selected to lead the global marketing function for Doribax with responsibility for establishing worldwide commercial strategy and organizational readiness. Set strategic direction for all U.S. commercial activities related to Levaquin IV, Doribax and Zeftera Established value added portfolio strategy targeted towards emerging hospital stakeholders (C-Suite, etc) Commercial leader on the Compound Development team for Zeftera and Doribax Exceeded Doribax launch forecast by 57% Provided US commercial assessment on numerous licensing and acquisition opportunities in infectious diseases

Led teams in all aspects of commercial development for two anti-infectives undergoing FDA review. Led strategic plan for indication sequencing and post approval medical affairs plan. Collaborated with HEOR on enhancing product value proposition. Established brand positioning, messaging, pricing, forecast, and comprehensive market entry and lifecycle strategies Built extended commercial teams incorporating internal business partners and external agencies Secured launch readiness approval for both brands from North American Leadership Team Served as US commercial lead with in licensing partner on co-promotion strategy and approach

Responsible for establishing the scientific platforms and value proposition for unique, hospital only drug device product. Instituted integrated pre-launch campaign to highlight the unmet need in post operative pain management. Incorporated all elements of marketing mix including personal and non-personal communications. Provided strategic guidance into the design of several HEOR projects to support the value proposition Assembled extensive network of KOL supporters across multiple specialties

Responsible for managing $1B Levaquin tablet forecast. Launch leader for the 750mg short course indication in CAP. Directed creative agency and cross functional team in the development of new positioning and commercial strategy to reenergize brand growth. Established unique pricing strategy to reduce exposure to fewer DOT's preventing a $100M downside Developed product packaging to provide competitive advantage Collaborated with regulatory to secure necessary labeling to support product messaging

Accountable for developing and executing the Levaquin non-retail strategy including hospitals, VA/DOD and LTC. Led the market introduction for the 750mg nosocomial pneumonia indication. Supervised team of two marketers and one microbiologist. Maintained 80% preferred formulary rate in the face of two competitive launches Established value proposition hypothesis to secure price premium

Led regional sales organization consisting of seven district sales managers and eighty five representatives. Responsible for the recruitment, selection and retention through multiple field sales expansions and realignments. Responsible for key customer management and development of value offerings in conjunction with our Strategic Business Group. Won three consecutive President's Pinnacle Club Awards (#1 region out of 15) Exceeded market share and forecasts each year for six years Developed numerous managers and representatives to assume additional responsibility